Advertisement
Research Article| Volume 22, P1-7, May 2018

Download started.

Ok

A systematic review about the epidemiology of primary progressive multiple sclerosis in Latin America and the Caribbean

Published:February 23, 2018DOI:https://doi.org/10.1016/j.msard.2018.02.024

      Highlights

      • A systematic review of the epidemiology of PPMS in LATAM was performed.
      • No incidence data were found regarding PPMS.
      • Differentiated prevalence was reported in 7 studies and ranged from 0.13 to 1.1 cases of PPMS per 100,000 inhabitants.
      • Regarding subtype frequency, PPMS was observed in 10% of affected patients in proportional meta-analysis.
      • The study provides information on discriminated epidemiological features of PPMS in the region.

      Abstract

      Novel epidemiological data has appeared in recent years in Latin America (LATAM) regarding the epidemiology of multiple sclerosis (MS); however, most of this information is related to all MS subtypes, and no specific data was collected regarding the primary progressive form of MS (PPMS). The objective of this study was to perform an updated systematic review of the epidemiology of PPMS in LATAM.

      Methods

      We conducted a systematic review of published epidemiological articles of PPMS from January 1997 to June 2017.

      Results

      No incidence data were found regarding PPMS. Differentiated prevalence was reported in 7 studies and ranged from 0.13 to 1.1 cases of PPMS per 100,000 inhabitants. Regarding subtype frequency, PPMS was observed in 10% of affected patients in proportional meta-analysis. No data about mortality were found.

      Conclusion

      The study provides information on discriminated epidemiological features of PPMS in the region. The frequency observed was low in terms of prevalence. Follow up studies considering survival milestones and incidence data could provide a better understanding of the disease in the region.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abad P.
        • et al.
        Prevalence of multiple sclerosis in Ecuador.
        Neurologia. 2010; 25: 309-313
        • Alves-Leon S.V.
        • et al.
        Multiple sclerosis outcome and morbi-mortality of a Brazilian cohort patients.
        Arq. Neuropsiquiatr. 2008; 66: 671-677
        • Arruda W.O.
        • et al.
        Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series.
        Arq. Neuropsiquiatr. 2001; 59: 165-170
        • Ascherio A.
        • Munger K.L.
        Environmental risk factors for multiple sclerosis. Part II: noninfectious factors.
        Ann. Neurol. 2007; 61: 504-513
        • Ascherio A.
        • Munger K.L.
        Environmental risk factors for multiple sclerosis. Part I: the role of infection.
        Ann. Neurol. 2007; 61: 288-299
        • Bach J.F.
        The effect of infections on susceptibility to autoimmune and allergic diseases.
        N. Engl. J. Med. 2002; 347: 911-920
        • Barahona J.
        • Montero A.
        • A F.
        Multiple sclerosis in Chile.
        Arq. Neuropsiquiatr. 2004; 62: 11
        • Cabrera-Gomez J.A.
        • et al.
        [Clinical characterization of patients with multiple sclerosis defined in Cuba].
        Rev. Neurol. 1998; 26: 723-728
        • Cabrera-Gomez J.A.
        • Lopez-Saura P.
        Alpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba.
        Rev. Neurol. 1999; 28: 849-858
        • Calmon A.B.
        • et al.
        Prevalence of multiple sclerosis in the city of Volta Redonda - Rio De Janeiro, Brazil using the capture-recapture method.
        Neuroepidemiology. 2016; 46: 88-95
        • Cardoso E.
        • et al.
        Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil.
        Arq. Neuropsiquiatr. 2006; 64: 727-730
        • Cobre P.
        • Smadja D.
        An epidemiologic study of multiple sclerosis in Martinique, French West Indies.
        Rev. Neurol. 2000; 156: 164-165
        • Cordova J.
        • Vargas S.
        • Sotelo J.
        Western and Asian features of multiple sclerosis in Mexican Mestizos.
        Clin. Neurol. Neurosurg. 2007; 109: 146-151
        • Correale J.
        • Farez M.
        Association between parasite infection and immune responses in multiple sclerosis.
        Ann. Neurol. 2007; 61: 97-108
        • Cristiano E.
        • et al.
        The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
        Mult. Scler. 2013; 19: 844-854
        • Cristiano E.
        • et al.
        Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.
        Mult. Scler. Relat. Disord. 2016; 9: 91-94
        • Cristiano E.
        • Patrucco L.
        • Rojas J.I.
        A systematic review of the epidemiology of multiple sclerosis in South America.
        Eur. J. Neurol. 2008; 15: 1273-1278
        • da Gama Pereira A.B.
        • et al.
        Prevalence of multiple sclerosis in Brazil: a systematic review.
        Mult. Scler. Relat. Disord. 2015; 4: 572-579
        • DerSimonian R.
        • Laird N.
        Meta-analysis in clinical trials.
        Control Clin. Trials. 1986; 7: 177-188
        • Ebers G.C.
        Environmental factors and multiple sclerosis.
        Lancet Neurol. 2008; 7: 268-277
        • Egger M.
        • et al.
        Bias in meta-analysis detected by a simple, graphical test.
        Bmj. 1997; 315: 629-634
        • von Elm E.
        • et al.
        The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
        Lancet. 2007; 370: 1453-1457
        • Eskandarieh S.
        • et al.
        Multiple sclerosis epidemiology in East Asia, South East Asia and South Asia: a systematic review.
        Neuroepidemiology. 2016; 46: 209-221
        • Evans C.
        • et al.
        Incidence and prevalence of multiple sclerosis in the Americas: a systematic review.
        Neuroepidemiology. 2013; 40: 195-210
        • Ferreira M.L.
        • et al.
        Epidemiology of 118 cases of multiple sclerosis after 15 years of follow-up on the reference center of Hospital da Restauracao, Recife, Pernambuco, Brazil.
        Arq. Neuropsiquiatr. 2004; 62: 1027-1032
        • Finkelsztejn A.
        • et al.
        Clinical features of multiple sclerosis in the south of Brazil: a partial analysis.
        Arq. Neuropsiquiatr. 2009; 67: 1071-1075
        • Fowkes F.G.
        • Fulton P.M.
        Critical appraisal of published research: introductory guidelines.
        BMJ. 1991; 302: 1136-1140
        • Gracia F.
        • et al.
        Prevalence and incidence of multiple sclerosis in Panama (2000–2005).
        Neuroepidemiology. 2009; 32: 287-293
        • Heydarpour P.
        • et al.
        Multiple sclerosis epidemiology in Middle East and North Africa: a Systematic review and meta-analysis.
        Neuroepidemiology. 2015; 44: 232-244
        • Kurtzke J.F.
        Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis.
        Neurol. Sci. 2000; 21: 383-403
        • Kurtzke J.F.
        Epidemiology and etiology of multiple sclerosis.
        Phys. Med Rehabil. Clin. N. Am. 2005; 16: 327-349
        • Lana-Peixoto M.A.
        • et al.
        The prevalence of multiple sclerosis in Belo Horizonte, Brazil.
        Arq. Neuropsiquiatr. 2012; 70: 102-107
        • Liberati A.
        • et al.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
        PLoS Med. 2009; 6: e1000100
        • Lublin F.D.
        • et al.
        Defining the clinical course of multiple sclerosis: the 2013 revisions.
        Neurology. 2014; 83: 278-286
        • Lublin F.D.
        • Reingold S.C.
        Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
        Neurology. 1996; 46: 907-911
        • McDonald W.I.
        • et al.
        Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
        Ann. Neurol. 2001; 50: 121-127
        • Moreira M.A.
        • et al.
        Multiple sclerosis: descriptive study of its clinical forms in 302 cases.
        Arq. Neuropsiquiatr. 2000; 58: 460-466
        • Negreiros A.A.
        • et al.
        Clinical and epidemiological profile of patients diagnosed with multiple sclerosis in Joao Pessoa, Paraiba, Brazil.
        Arq. Neuropsiquiatr. 2015; 73: 741-745
        • Noseworthy J.H.
        • et al.
        Multiple sclerosis.
        N. Engl. J. Med. 2000; 343: 938-952
      1. Polman, C.H., et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 69(2): p. 292-302.

        • Polman C.H.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria".
        Ann. Neurol. 2005; 58: 840-846
        • Poser C.M.
        • et al.
        New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
        Ann. Neurol. 1983; 13: 227-231
        • Ribeiro S.B.
        • et al.
        Clinical and epidemiological profile of patients with multiple sclerosis in Uberaba, Minas Gerais, Brazil.
        Arq. Neuropsiquiatr. 2011; 69: 184-187
        • Risco J.
        • et al.
        Latitudinal prevalence gradient of multiple sclerosis in Latin America.
        Mult. Scler. 2011; 17: 1055-1059
        • Sanchez J.L.
        • et al.
        Prevalence of multiple sclerosis in Colombia.
        Rev. Neurol. 2000; 31: 1101-1103
        • Sanchez J.L.
        • et al.
        Clinical features of multiple sclerosis in a genetically homogeneous tropical population.
        Mult. Scler. 2001; 7: 227-229
        • Simpson Jr, S.
        • et al.
        Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.
        J. Neurol. Neurosurg. Psychiatry. 2011; 82: 1132-1141
        • Stroup D.F.
        • et al.
        Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group.
        JAMA. 2000; 283: 2008-2012
        • Takkouche B.
        • Cadarso-Suarez C.
        • Spiegelman D.
        Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis.
        Am. J. Epidemiol. 1999; 150: 206-215
        • Toro J.
        • et al.
        Prevalence of multiple sclerosis in Bogota, Colombia.
        Neuroepidemiology. 2007; 28: 33-38
        • Trapp B.D.
        • et al.
        Axonal transection in the lesions of multiple sclerosis.
        N. Engl. J. Med. 1998; 338: 278-285
        • Velazquez-Quintana M.
        • et al.
        [Multiple sclerosis in Mexico: a multicentre study].
        Rev. Neurol. 2003; 36: 1019-1022